PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 1, 2022Journal for ImmunoTherapy of Cancer289 citationsOpen Access

Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma

JLJun LiuYYYang YangZLZhichao Liu

Key Points

Key points are not available for this paper at this time.

Abstract

ChiCTR1900026240.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Liu et al. (2022) studied this question.

synapsesocial.com/papers/69dd5d92629747396240c5b7https://doi.org/10.1136/jitc-2021-004291
Ask AI
Helpful
Bookmark
Share
View Full Paper